Evolus
(NASDAQ:EOLS)
12.78
0.62[5.10%]
At close: Jun 24
12.7899
0.0099[0.08%]
After Hours: 5:57PM EDT
Day High/Low12.18 - 12.79
52 Week High/Low5.06 - 14.34
Open / Close12.28 / 12.78
Float / Outstanding40.6M / 56M
Vol / Avg.762.1K / 503.4K
Mkt Cap716.3M
P/E-
50d Avg. Price11.84
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float40.6M

Evolus (NASDAQ:EOLS), Quotes and News Summary

Evolus (NASDAQ: EOLS)

Day High/Low12.18 - 12.79
52 Week High/Low5.06 - 14.34
Open / Close12.28 / 12.78
Float / Outstanding40.6M / 56M
Vol / Avg.762.1K / 503.4K
Mkt Cap716.3M
P/E-
50d Avg. Price11.84
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float40.6M
Benzinga - Dec 20, 2021, 8:46AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary of 900 kilodalton or kDa, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. The company generates product revenue from the sale of Jeuveau in the US.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-0.330-0.310 0.0200
REV30.570M33.908M3.338M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Evolus Questions & Answers

Q
How do I buy Evolus (EOLS) stock?
A

You can purchase shares of Evolus (NASDAQ: EOLS) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for Evolus (EOLS) stock?
A

The latest price target for Evolus (NASDAQ: EOLS) was reported by Needham on Thursday, June 23, 2022. The analyst firm set a price target for 18.00 expecting EOLS to rise to within 12 months (a possible 40.85% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Evolus (EOLS)?
A

The stock price for Evolus (NASDAQ: EOLS) is $12.78 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Evolus (EOLS) pay a dividend?
A

There are no upcoming dividends for Evolus.

Q
When is Evolus (NASDAQ:EOLS) reporting earnings?
A

Evolus’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Evolus (EOLS) going to split?
A

There is no upcoming split for Evolus.

Q
What sector and industry does Evolus (EOLS) operate in?
A

Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.